Regenique Group Limited (RGGG)
Regenique Group will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
2,000,000
Deal Size
$9.00M

Company Description

Regenique Group is a customer-centric, science-backed aesthetics services provider.

We prioritize delivering an unparalleled, premium experience for our customers by emphasizing safety, privacy and patient comfort.

In addition to the market’s prevailing medi-aesthetics treatments, our suite of science-backed aesthetics services also includes bio-regenerative treatments and other advanced therapies.

Our services are rendered through five strategically located clinics staffed by experienced doctors and equipped with advanced medical devices.

Our mission is to elevate the overall well-being of our customers by offering personalized anti-aging and longevity healthcare and aesthetics solutions.

Regenique Group Limited
CountrySingapore
Founded2009
IndustryMedical Care Facilities
SectorHealthcare
Employees58
CEOMr. Wong Ming Kwong

Contact Details

Address:
10 Sinara Drive
#10-25 Square 2, 307506
Singapore
Phone+65 8383 0544
Websiteregeniquegroup.com

Stock Details

Ticker SymbolRGGG
ExchangeNASDAQ
Fiscal YearOctober - September
Reporting CurrencySGD
CIK Code0002063022
SIC Code8011

Key Executives

NamePosition
Mr. Wong Ming KwongExecutive Chairman and Chief Executive Officer
Mr. Then Chee TatExecutive Director, Chief Financial Officer and Deputy Chief Executive Officer
Dr. Shiau Ee LengChief Medical Officer

Latest SEC Filings

DateTypeTitle
Oct 31, 2025F-1Registration statement for certain foreign private issuers
Sep 2, 2025DRS/A[Amend] [Cover] Draft Registration Statement
Aug 8, 2025DRS/A[Amend] [Cover] Draft Registration Statement
Jul 18, 2025DRS/A[Amend] [Cover] Draft Registration Statement
May 23, 2025DRS[Cover] Draft Registration Statement